Does NAD+ Actually Work? A Straight Look at the Real Research

Here is the honest answer, up front: raising your NAD+ definitely works. Whether raising it changes how you feel is where the science gets interesting — and where most of the internet stops telling the truth. NAD+ has become the most hyped molecule in wellness, which means it now attracts both breathless overclaiming and reflexive dismissal. Neither is accurate. Below is what the actual human research says, organized by how confident we can be about it, with the weak spots left in.

First, Why This Molecule Gets So Much Attention

Nicotinamide adenine dinucleotide — NAD+ — isn't a vitamin or a stimulant. It's a coenzyme found in every living cell you have, and it does two jobs that happen to sit at the center of aging biology.

The first job is energy. NAD+ is the electron shuttle your mitochondria use to convert food into ATP. No NAD+, no cellular energy — this isn't a marketing claim, it's textbook biochemistry.

The second job is why longevity researchers care. NAD+ is the required fuel for two families of repair enzymes: sirtuins, which regulate gene expression and mitochondrial health, and PARPs, which repair damaged DNA. Both consume NAD+ to function. So when NAD+ runs low, your cells don't just make less energy — they also repair themselves less aggressively.

Add a third factor and the picture sharpens: an enzyme called CD38, which degrades NAD+, becomes more active with age and inflammation. You're producing less and burning through more at the same time.

This is the crux of the entire NAD+ story: it is simultaneously the currency your cells spend on energy and the currency they spend on repair. When it gets scarce, the cell has to choose.

The Evidence Scorecard

Most NAD+ content treats every claim as equally supported. It isn't. Here is the same body of research sorted by how much weight it can actually carry — from findings measured directly in human tissue to claims that exist only in mice.

The Part Nobody Disputes: NAD+ Falls, and You Can Raise It

Two findings in this field are about as solid as clinical nutrition research gets.

The decline is measurable in human tissue. Not inferred from mice — measured. Skin biopsy analysis found NAD+ concentrations drop by at least 50% across adult aging, with adults sitting far below newborn levels. Liver tissue collected during surgery showed roughly a 30% decline between donors under 45 and donors over 60. Different tissues, different methods, same direction.

Repletion works, and it's repeatable. This is the single most consistently replicated result in NAD+ research. Randomized trials show 1 g/day of nicotinamide riboside for 14 days roughly doubles whole-blood NAD+ versus placebo. Six weeks at 1,000 mg/day raised NAD+ inside immune cells about 60%. Heart-failure patients on up to 2,000 mg/day also doubled their blood NAD+. In Parkinson's trials, researchers went further and confirmed NAD+ rising in the brain itself using imaging.

So the pharmacology is settled. You can move this number, on purpose, in humans. That is not a small thing — it is the necessary first step for everything else.

The Middle Ground: Real Biological Shifts, Modest Human Effects

Between “NAD+ went up” and “my life improved” sits a growing pile of intriguing, imperfect studies.

Mitochondria and inflammation

The Parkinson's disease trials are the most informative work in the entire field, because researchers biopsied and sequenced rather than just asking people how they felt. NAD+ repletion upregulated genes governing mitochondrial, lysosomal, and proteasomal function — the cell's power plants, recycling centers, and protein-disposal systems — while reducing inflammatory cytokines. Some patients showed mild clinical improvement, but the authors were explicit that this needs larger trials. Heart-failure work found a similar pattern: higher NAD+ correlated with better mitochondrial respiration and lower inflammatory markers.

Performance and metabolism

A six-week randomized trial in amateur runners found that NMN combined with training raised ventilatory thresholds in a dose-dependent way — meaning higher doses produced bigger gains, which is exactly the pattern you want to see if an effect is real rather than noise. The proposed mechanism was improved oxygen utilization in skeletal muscle. Separate research found NMN increased muscle insulin sensitivity in overweight, prediabetic women. Studies in older adults have reported better maintained walking speed and improved sleep quality.

And the trials that found nothing

Honesty requires this paragraph. Other trials in older patients with existing diabetes and physical impairment found no significant improvement in walking speed or grip strength. Heart-failure trials doubled blood NAD+ and still showed no significant difference in cardiac outcomes. The most sober assessment came in 2026, when a systematic review pooled 15 placebo-controlled RCTs across 740 participants and concluded that dosing, populations, and lab assays were too inconsistent to combine cleanly. It graded the certainty of evidence Very Low and found no statistically significant difference between NMN and NR across 14 comparable metabolic outcomes.

The correct read on that isn't “NAD+ doesn't work.” It's that the field is where vitamin D research was fifteen years ago: mechanism understood, biomarker movable, optimal dose and best-responder population still unknown.

What About IV NAD+ Specifically?

This is the question we get most, and it deserves a careful answer rather than a confident one.

There is no published head-to-head randomized trial comparing IV NAD+ to oral precursors. Anyone claiming a specific multiple — “IV is 10x more effective” — is extrapolating, not citing.

What we do have is a genuinely useful 2019 pharmacokinetic study in healthy men. Researchers infused 750 mg of NAD+ over six hours — about 2 mg per minute — and tracked plasma and urine. The findings were more interesting than expected:

• Nothing happened for roughly two hours. Plasma NAD+ and its metabolites showed no measurable rise for the first stretch of the infusion — evidence of a real metabolic buffer absorbing the dose before blood levels move.
• Then levels climbed sharply, with plasma NAD+ up roughly 400% by the six-hour mark, alongside comparable rises in nicotinamide and other metabolites.
• NMN spiked after the drip ended, elevated at the eight-hour mark — the body was still actively processing the dose two hours later.
• NAD+ appeared intact in urine, showing that some of any infused dose is simply excreted. More is not automatically better.

Two practical conclusions fall out of that data. First, the honest case for IV is mechanical, not magical: it bypasses digestion entirely and allows a single dose far larger than any capsule. Second — and this is the part worth knowing before you book — the slow drip rate is the whole point. The flushing, chest pressure, nausea, and cramping people associate with NAD+ are rate-dependent. Slowing the infusion is the single most effective comfort lever there is, which is why a real NAD+ session is a long appointment and not a quick drip.

A BS Detector for NAD+ Claims

You're going to keep seeing NAD+ headlines. Four questions will sort almost all of them:

• Human or mouse? Most spectacular NAD+ results — including every lifespan claim — come from mice, yeast, or worms. Interesting, but a mouse is not a person and the dose scaling doesn't translate cleanly.
• Biomarker or outcome? “NAD+ increased 2-fold” is a biomarker. “Participants walked farther” is an outcome. Both matter; only the second is something you'd notice.
• Was there a placebo group? Fatigue and brain fog are exquisitely placebo-sensitive. Uncontrolled studies of “energy and focus” tell you almost nothing.
• How many people? Much of this literature runs on 8–30 participants. That's hypothesis-generating, not conclusive — and it's exactly why that 2026 review landed on Very Low certainty.

So What's the Reasonable Way to Use It?

The evidence supports a specific posture: treat NAD+ as a mechanistically well-grounded, well-tolerated intervention with promising but immature outcome data. That means going in with a defined goal, a defined trial period, and a way to judge whether it worked for you.

At Prime IV Hydration & Wellness in Jones Valley, NAD+ shows up in three formats, and the right one depends on how deep you want to go:

• Full NAD+ infusions (500mg and 1,000mg, from $499) — the highest-dose option, and the one the pharmacokinetic data above actually describes. Pre-order required so we can schedule the longer chair time comfortably.
• NAD+ injections (100mg and 250mg, from $75) — a lower commitment way to try it consistently over weeks rather than in one large session.
• Niagen® (nicotinamide riboside) — notably, this is the exact precursor used in most of the human trials cited above. If you want the molecule with the deepest clinical literature behind it, this is it. We break down the tradeoffs in NAD+ vs. Niagen.

One practical note that matters more than most people realize: how you prepare changes the experience. Support nutrients like glutathione, B-12, alpha lipoic acid, and magnesium are the reasoning behind the NAD+ Amplifier — here's how to get more out of a NAD+ session. And if you're still deciding whether the molecule makes sense for you at all, start with what NAD+ actually is or the bigger picture in how to build your healthspan.

Who tends to be a good fit

• Adults with persistent fatigue or mental fog who have already covered the basics — sleep, hydration, thyroid and iron labs, B-12 status. NAD+ is a poor substitute for an undiagnosed deficiency.
• High-output people over 40 in a demanding training or work cycle, where the performance and recovery signals are most encouraging.
• People in recovery programs, where NAD+ has its longest real-world clinical track record.

Who should skip it

• Anyone expecting a cure, a reversal of aging, or a replacement for medical treatment of a diagnosed condition.
• Anyone unwilling to sit for a long, slow infusion — rushing it is what makes NAD+ uncomfortable.
• Anyone who hasn't been screened. New clients in Alabama complete a one-time $25 telehealth screening, and that conversation is genuinely where the “is this right for you” question gets answered.

The most defensible summary we can give you: the mechanism is real, the age-related decline is real, the ability to raise NAD+ in humans is proven, the safety record at studied doses is good, and the clinical-outcome evidence is early and mixed. That's a reasonable thing to try with clear expectations. It is not a miracle, and anyone who tells you otherwise hasn't read the trials.

IV therapy and NAD+ services at Prime IV Hydration & Wellness are administered by licensed medical professionals and support wellness as part of a healthy lifestyle. These statements have not been evaluated by the FDA, and this article is educational information — not medical advice, and not intended to diagnose, treat, cure, or prevent any disease. Talk with our medical team or your own physician about your situation.

Frequently Asked Questions